BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28000339)

  • 1. People with epilepsy receive more statins than the general population but have no higher cardiovascular risk: results from a cross-sectional study.
    Vivanco-Hidalgo RM; Elosua R; Gómez González A; Moreira A; Díez L; Grau M; Degano IR; Roquer J
    Eur J Neurol; 2017 Feb; 24(2):419-426. PubMed ID: 28000339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of cardiovascular risk factors in people with epilepsy.
    Vivanco-Hidalgo RM; Gomez A; Moreira A; Díez L; Elosua R; Roquer J
    Brain Behav; 2017 Feb; 7(2):e00618. PubMed ID: 28239528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antiepileptic drugs and lipid-lowering agents in the United States.
    Mintzer S; Maio V; Foley K
    Epilepsy Behav; 2014 May; 34():105-8. PubMed ID: 24735835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epilepsy, antiepileptic drugs, and the risk of major cardiovascular events.
    Lee-Lane E; Torabi F; Lacey A; Fonferko-Shadrach B; Harris D; Akbari A; Lyons RA; Rees MI; Sawhney I; Halcox J; Powell R; Pickrell WO
    Epilepsia; 2021 Jul; 62(7):1604-1616. PubMed ID: 34046890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-morbidity and clinically significant interactions between antiepileptic drugs and other drugs in elderly patients with newly diagnosed epilepsy.
    Bruun E; Virta LJ; Kälviäinen R; Keränen T
    Epilepsy Behav; 2017 Aug; 73():71-76. PubMed ID: 28622547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: a cross-sectional cohort study.
    Kutkienė S; Petrulionienė Ž; Laucevičius A; Petrylaitė M; Maskeliūnaitė D; Puronaitė R; Kovaitė M; Kalibaitaitė I; Rinkūnienė E; Dženkevičiūtė V; Kasiulevičius V
    Lipids Health Dis; 2018 Apr; 17(1):88. PubMed ID: 29673349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and factors associated with statin use in high-risk patients with type 1 diabetes from a specialized diabetes unit.
    Amor AJ; Ortega E; Giménez M; Cofán M; Blanco J; Pané A; Boswell L; Vinagre I; Esmatjes E; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Oct; 66(8):512-519. PubMed ID: 31000451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
    Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
    J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent lipid abnormalities in statin-treated coronary artery disease patients with and without diabetes in China.
    Wei Y; Guo H; The E; Che W; Shen J; Hou L; Zhao S; Ye P; Li G; Wang D; Jie Q; Hu D
    Int J Cardiol; 2015 Mar; 182():469-75. PubMed ID: 25612824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
    Gitt AK; Drexel H; Feely J; Ferrières J; Gonzalez-Juanatey JR; Thomsen KK; Leiter LA; Lundman P; da Silva PM; Pedersen T; Wood D; Jünger C; Dellea PS; Sazonov V; Chazelle F; Kastelein JJ;
    Eur J Prev Cardiol; 2012 Apr; 19(2):221-30. PubMed ID: 21450578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.
    Izzo R; de Simone G; Trimarco V; Giudice R; De Marco M; Di Renzo G; De Luca N; Trimarco B
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1101-6. PubMed ID: 23419735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent dyslipidemia in statin-treated patients: the focus on comprehensive lipid management survey in Swiss patients.
    Sudano I; Hess L; Noll G; Arnet D
    Swiss Med Wkly; 2011; 141():w13200. PubMed ID: 21574067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular risk profile in 40-year old men and 50-year old women in the Czech Republic: results of a cross-sectional survey].
    Vrablík M; Chmelík Z; Lánská V
    Vnitr Lek; 2014 Nov; 60(11):991-7. PubMed ID: 25600047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins use for primary prevention of cardiovascular disease: A population-based digitally enabled real-world evidence cross-sectional study in primary care in Brazil.
    Santo K; Santos RD; Girotto AN; Nieri J; Monfardini F; Raupp P; Pereira PM; Berwanger O; Machline-Carrion MJ
    J Clin Lipidol; 2024; 18(3):e384-e393. PubMed ID: 38431498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study.
    Liu JC; Yang TY; Hsu YP; Hao WR; Kao PF; Sung LC; Chen CC; Wu SY
    Oncotarget; 2016 Sep; 7(37):59618-59629. PubMed ID: 27517752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].
    Pérez A; González Blanco C; Hernández-Presa MÁ; Chaves J
    Endocrinol Nutr; 2011; 58(6):283-90. PubMed ID: 21641286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study.
    Chapman RH; Petrilla AA; Berman L; Benner JS; Tang SS
    Am J Cardiovasc Drugs; 2009; 9(5):299-308. PubMed ID: 19791839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.
    Armenian SH; Sun CL; Vase T; Ness KK; Blum E; Francisco L; Venkataraman K; Samoa R; Wong FL; Forman SJ; Bhatia S
    Blood; 2012 Nov; 120(23):4505-12. PubMed ID: 23034279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction.
    Mortensen MB; Kulenovic I; Falk E
    Cardiovasc Diabetol; 2016 May; 15():81. PubMed ID: 27229923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.